Nintedanib Exhibits Superior Cost-Effectiveness to Pirfenidone for Treatment of IPF, Study Finds AJMC, 25 Jan 2020 Researchers compared the cost-effectiveness of ninetedanib to pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF…